TcLand Expression-Product Pipeline Analysis, 2017 Update

TcLand Expression-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME131127PD
  • |
  • Pages: 22
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

TcLand Expression (TcLand) is a developer of companion diagnostics in immune mediated disorders and biomarkers in solid organ transplantation. The company develops companion diagnostics based on its gene expression biomarkers platform. Its research and development platform develops and validates invasive multi-genes molecular diagnostic blood tests. TcLand's clinical development programs include RA-INF-Dx Test, IMD Dx2, IMD Dx3 and L-TolX test. The company also offers liver transplantation and rheumatoid arthritis services. It partners with pharma and biotech companies for the development of companion diagnostics. TcLand is headquartered in Mulhouse, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company TcLand Expression

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

TcLand Expression Company Overview 4

TcLand Expression Company Snapshot 4

TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4

TcLand Expression-Pipeline Analysis Overview 7

TcLand Expression-Key Facts 7

TcLand Expression-Major Products and Services 8

TcLand Expression Pipeline Products by Development Stage 9

TcLand Expression Pipeline Products Overview 11

IMD Dx2 11

IMD Dx2 Product Overview 11

IMD Dx3 12

IMD Dx3 Product Overview 12

L-TolX 13

L-TolX Product Overview 13

RA-INF-Dx 14

RA-INF-Dx Product Overview 14

TcLand Expression-Key Competitors 15

TcLand Expression-Key Employees 16

TcLand Expression-Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

TcLand Expression, Recent Developments 18

Jun 17, 2011: TcLand Expression Receives EUR1.2m From Oseo And ERDF To Support Project In Personalized Medicine 18

Appendix 19

Methodology 19

About GlobalData 21

Contact Us 21

Disclaimer 21

List of Figures

TcLand Expression Pipeline Products by Equipment Type 5

TcLand Expression Pipeline Products by Development Stage 9

List of Tables

TcLand Expression Pipeline Products and Ongoing Clinical Trials Overview 4

TcLand Expression Pipeline Products by Equipment Type 5

TcLand Expression Pipeline Products by Indication 6

TcLand Expression, Key Facts 7

TcLand Expression, Major Products and Services 8

TcLand Expression Number of Pipeline Products by Development Stage 9

TcLand Expression Pipeline Products Summary by Development Stage 10

IMD Dx2-Product Status 11

IMD Dx2-Product Description 11

IMD Dx3-Product Status 12

IMD Dx3-Product Description 12

L-TolX-Product Status 13

L-TolX-Product Description 13

RA-INF-Dx-Product Status 14

RA-INF-Dx-Product Description 14

TcLand Expression, Key Employees 16

Glossary 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

TcLand Expression, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 54278
Site License
USD 1500 INR 108555
Corporate User License
USD 2250 INR 162833

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com